Warning! GuruFocus detected
1 Severe warning sign
with 1781.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Health & Life Co Ltd
ISIN : TW0001781003
Description
Health & Life Co Ltd manufactures medical devices in the fields of cardiovascular disease and in-vitro diagnostics in Taiwan. Its product portfolio includes blood pressure monitor series, nebulizer, and blood glucose monitoring system, blood glucose stripes and Thermometer.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.3 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | 3.85 | |||||
Interest Coverage | 0.74 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.24 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.5 | |||||
3-Year Book Growth Rate | 1.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.64 | |||||
9-Day RSI | 29.81 | |||||
14-Day RSI | 29.5 | |||||
3-1 Month Momentum % | -4.6 | |||||
6-1 Month Momentum % | -0.9 | |||||
12-1 Month Momentum % | 5.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.62 | |||||
Quick Ratio | 2.03 | |||||
Cash Ratio | 1.25 | |||||
Days Inventory | 100.76 | |||||
Days Sales Outstanding | 68 | |||||
Days Payable | 105.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.34 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 20.92 | |||||
Operating Margin % | 0.35 | |||||
Net Margin % | 3.43 | |||||
FCF Margin % | 4.27 | |||||
ROE % | 6.72 | |||||
ROA % | 3.32 | |||||
ROIC % | 0.59 | |||||
3-Year ROIIC % | 2473.42 | |||||
ROC (Joel Greenblatt) % | 12.21 | |||||
ROCE % | 7.08 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26.25 | |||||
PE Ratio without NRI | 26.19 | |||||
Price-to-Owner-Earnings | 30.26 | |||||
PS Ratio | 0.88 | |||||
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 1.53 | |||||
Price-to-Free-Cash-Flow | 30.51 | |||||
Price-to-Operating-Cash-Flow | 26.08 | |||||
EV-to-EBIT | 16.61 | |||||
EV-to-EBITDA | 9.6 | |||||
EV-to-Revenue | 0.75 | |||||
EV-to-FCF | 18.27 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Graham-Number | 1.33 | |||||
Price-to-Net-Current-Asset-Value | 3.81 | |||||
Earnings Yield (Greenblatt) % | 6.02 | |||||
FCF Yield % | 5.05 |